The Rheumatologist
COVID-19 NewsACR Convergence
You are here: Home / Articles / Pegloticase & Methotrexate Combination Therapy May Benefit Patients with Uncontrolled Gout

Pegloticase & Methotrexate Combination Therapy May Benefit Patients with Uncontrolled Gout

• By

Reference

  1. Albert J, Hosey T, LaMoreaux B, et al. Subcutaneous or oral methotrexate exposure and response to pegloticase in uncontrolled gout patients in a community rheumatology practice [abstract 1236]. Arthritis Rheumatol. 2019 Oct; 71(suppl 10).

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »